IX
ORIX Corporation
NYSEUSDEQUITY
Financial Services
DELAYED
Last price
38.49
▲ 0.95 (2.53%)
MARKET · —
Price
Open
38.44
Prev close
37.54
Day high
38.69
Day low
38.42
Volume
187.20K
Market cap
$41.81B
P/E (TTM)
10.81
52W range
24.19 – 42.39
Trailing performance
Returnvs SPY
1W
-4.16%
-2.8%
1M
-4.01%
-7.7%
3M
-1.96%
-5.1%
6M
+8.91%
-2.2%
YTD
+31.72%
+19.4%
1Y
+49.71%
+29.7%
3Y
+120.22%
+46.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$41.81B
Enterprise value$5.51T
Revenue (TTM)$3.46T
Gross profit$1.51T
EBITDA$1.15T
Net income$623.13B
EPS (TTM)$3.56
Free cash flow—
Total cash$968.92B
Total debt$6.31T
Book value / share$27.00
Shares outstanding1.09B
Float1.08B
Short % of float0.07%
Dividend yield2.57%
Beta (5Y)0.72
Valuation & profitability ratios
Trailing P/E10.81
Forward P/E—
PEG ratio2.72
Price / sales—
Price / book1.43
EV / revenue1.59
EV / EBITDA4.78
Gross margin43.61%
Operating margin21.52%
Profit margin17.94%
Return on equity14.04%
Return on assets2.65%
Debt / equity130.28
Current ratio1.68
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Total revenue | $3.33T | $2.87T | $454.81B | $2.67T |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $447.26B | $351.63B | $146.69B | $273.07B |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net income | $447.26B | $351.63B | $146.69B | $273.07B |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 4.90 | 1 | $3.49T | +387.5% |
| Next year | 3.00 | 1 | $3.56T | +2.0% |
Analyst targets & ownership
Mean target$41.38
High target$41.38
Low target$41.38
Implied upside7.51%
Analyst count1
ConsensusHOLD
Strong buy / Buy0 / 0
Hold1
Sell / Strong sell0 / 0
Held by insiders0.00%
Held by institutions3.46%
Institutions holding364
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Moving averages & technicals
SMA 10
39.35
-2.20% from price
SMA 20
39.78
-3.25% from price
SMA 50
39.52
-2.62% from price
SMA 100
37.06
+3.87% from price
SMA 200
33.53
+14.80% from price
EMA 12
39.20
-1.82% from price
EMA 26
39.50
-2.54% from price
EMA 50
39.06
-1.47% from price
RSI (14)
43.3
Neutral
MACD (12,26,9)
-0.29
Hist -0.32
ATR (14)
0.84
2.17% of price
Realised vol 30D
32.5%
Annualised
Bollinger upper
41.79
20, 2σ
Bollinger lower
37.78
20, 2σ
50 / 200 cross
Golden
39.52 vs 33.53
Trend bias
Above 200
+14.80%
Risk profile
Beta vs SPY
0.97
Less volatile than market
Correlation to SPY
0.44
Loosely linked
Realised vol 30D
32.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-20.3%
Peak to trough
Max drawdown 5Y
-39.0%
Peak to trough
ATR 14
0.84
2.17% of price
Beta (reported)
0.72
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
ORIX (TSE:8591) Raised Dividend Guidance Under A Revised Dividend Policy
Simply Wall St. · 3d ago
IX or FUTU: Which Is the Better Value Stock Right Now?
Zacks · 10d ago
Are Investors Undervaluing Orix Corp Ads (IX) Right Now?
Zacks · 10d ago
New Strong Buy Stocks for August 12th
Zacks · 10d ago
Orix Corp Ads Q1 Earnings Call Highlights
MarketBeat · 14d ago
Orix: Fiscal Q1 Earnings Snapshot
Associated Press · 16d ago
IX vs. FUTU: Which Stock Is the Better Value Option?
Zacks · 29d ago
Hilco Global Provides $65 Million FILO Loan to a National Specialty Retailer
PR Newswire · 30d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.